December 13, 2024. We prayed through every moment. The surgeon, hesitant yet dedicated, reassured us with his promise. Two days later, I received the pathology report, full of technical terms most would prefer to ignore: Recurrent leiomyosarcoma of the thyroid. It described a well-defined swelling just above the hyoid bone, measuring about 4.3 by 3.5 centimetres, grey, yellowish, and firm. Under the microscope, it was a battlefield: spindle-shaped cells, abnormal nuclei, scattered necrosis, inflammatory cells, and invading muscle fibers. 

The mitotic count was nine to ten per high-power field, an alarming sign. Margins were mixed; the superior and inferior edges were clear, but the anterior and 9 o’clock margins were not, suggesting possible microscopic residual tumour. Immunohistochemistry confirmed the diagnosis: TTF, PAX8, and CK were negative; SMA was negative; Desmin was positive; CD34 was positive; Ki-67 was 15%. 

In simple terms, it was sarcoma, again, this time reaching the hyoid bone. The pathologist noted: Features are of sarcoma, swelling over hyoid bone. Differential diagnoses included leiomyosarcoma, rhabdomyosarcoma, or anaplastic thyroid carcinoma. 

The surgeon’s silence spoke volumes. 

Despite all efforts, leiomyosarcoma proved relentless. My grandma faced these days with quiet resilience, sensing its return but rarely speaking of it. For her, it was about another chance, not just to survive, but to understand and accept her situation, freeing her from doubts about whether she deserved it. After the second surgery, she remained fragile but stable. The doctors administered antibiotics, painkillers, and strict hormone replacements for her thyroid, which she took conscientiously. Every pill was measured, every dose recorded; my family ensured she never missed one. 

The removed tumour samples were preserved in formalin bottles stored in her wardrobe, an unspoken symbol of her survival. She carried them to every follow-up, trembling hands clutching her proof of endurance. She appeared to stabilise for a few weeks: wounds healed, appetite improved, voice faintly returning. But the true battle was still ahead. About a month later, the hospital arranged radiation therapy, which should have started after her first surgery. She was referred to Ramaiah Institute of Oncology and Memorial Hospital for treatment. I accompanied her every step. I watched her sit quietly in waiting rooms, her sari covering the scar like a pale necklace. The fear from before was replaced by a calm I cannot quite explain, neither hope nor despair, but perhaps acceptance, a quiet courage that needs no announcement. Each session weakened her, causing fatigue, nausea, and loss of appetite. Yet she never complained. She said, “I’ve already faced the knife twice. This light, this machine, it doesn’t scare me.” Finally, everything aligned: the treatments, follow-ups, and routine. For the first time since this nightmare began, there was no confusion, only discipline and a small, unwavering hope that perhaps the worst was behind us.